JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iino, T.
Right arrow Articles by Kuriyama, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iino, T.
Right arrow Articles by Kuriyama, K.

Effect of vinconate, an indolonaphthyridine derivative, on dopamine and serotonin concentrations in dialysate from the striatum of freely moving rats: brain microdialysis studies

T Iino, M Katsura and K Kuriyama

Department of Pharmacology, Kyoto Prefectural University of Medicine, Japan.

The effect of (+/-)-methyl 3-ethyl-2,3,3a, 4-tetrahydro-1H-indolo[3,2,1- de][1,5]naphthyridine -6-carboxylate monohydrochloride (vinconate), an indolonaphthyridine derivative, on dopamine and serotonin concentrations in dialysate from the striatum of freely moving rats was examined by brain microdialysis. Twenty-minute samples collected were used to determine dopamine and serotonin by high-performance liquid chromatography in a single run. The basal extracellular levels of dopamine and serotonin were 41.12 +/- 5.04 and 10.41 +/- 1.71 (fmol/20 min), respectively. Dopamine concentrations in dialysate were significantly increased after a single treatment with vinconate (50-200 mg/kg p.o.). Tetrodotoxin (10 microM) added into the dialysis perfusate decreased dopamine concentrations in dialysate and vinconate had no effect on dopamine concentrations in dialysate when administered after tetrodotoxin. The vinconate-induced increase in dialysate dopamine concentrations was significantly reduced by scopolamine (1 microM) and N0434 (1 microM), respectively. Moreover, daily treatment with vinconate (25 mg/kg p.o.) for 7 days resulted in enhanced dopamine and serotonin concentrations in dialysate induced by subsequent vinconate treatment. These findings suggest that vinconate administered systemically can enhance dialysate dopamine concentrations and this effect may be related to the muscarinic receptor and the dopamine D2 receptor. The present findings also suggest that repeated treatment with vinconate may augment these effects of vinconate on dopamine and serotonin concentrations in dialysate from the brain.

Volume 278, Issue 2, pp. 614-619, 08/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.